Chutes & Ladders—Alchemab CEO resigns immediately citing ‘personal reasons’
Chutes & Ladders—Alchemab CEO resigns immediately citing ‘personal reasons’ mbayer [...]
ASCO: Merck’s Keytruda combo data could spark hope for lymphoma patients who lack options
ASCO: Merck’s Keytruda combo data could spark hope for lymphoma [...]
Avadel’s shares crumble as narcolepsy drug delayed yet again, this time on patent issue
Avadel’s shares crumble as narcolepsy drug delayed yet again, this [...]
Vertex scoops up Catalyst’s complement pipeline for $60M cash
Vertex scoops up Catalyst’s complement pipeline for $60M cash mbayer [...]
With the right partner, Pfizer gains fast-track tag for previously shelved NASH drug
With the right partner, Pfizer gains fast-track tag for previously [...]
IN-ACTIV: NRx tanks as peptide fails NIH trial in severe COVID-19 patients
IN-ACTIV: NRx tanks as peptide fails NIH trial in severe [...]
Forte fields demand to liquidate from top shareholder who says latest asset came ‘out of thin air’
Forte fields demand to liquidate from top shareholder who says [...]
With failed COVID shot still dragging on earnings, CureVac tries to turn page to next-gen mRNA tech
With failed COVID shot still dragging on earnings, CureVac tries [...]
Antios rocked as hepatitis B safety signal sparks clinical hold, termination of collaboration
Antios rocked as hepatitis B safety signal sparks clinical hold, [...]
CSL Behring gene therapy makes comeback after hold for FDA priority review
CSL Behring gene therapy makes comeback after hold for FDA [...]